BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:31PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 32.05B |
| Enterprise value | 18.01B |
| Trailing P/E | 3.07 |
| Forward P/E | 16.67 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.71 |
| Price/book (mrq) | 1.62 |
| Enterprise value/revenue | 0.97 |
| Enterprise value/EBITDA | 1.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.24 |
| 52-week change 3 | -22.93% |
| S&P500 52-week change 3 | -13.21% |
| 52-week high 3 | 189.07 |
| 52-week low 3 | 117.08 |
| 50-day moving average 3 | 137.08 |
| 200-day moving average 3 | 147.89 |
Share statistics
| Avg vol (3-month) 3 | 671.01k |
| Avg vol (10-day) 3 | 579k |
| Shares outstanding 5 | 242.68M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 90.32M |
| % held by insiders 1 | 64.01% |
| % held by institutions 1 | 18.17% |
| Shares short (14 Mar 2023) 4 | 1.79M |
| Short ratio (14 Mar 2023) 4 | 2.89 |
| Short % of float (14 Mar 2023) 4 | N/A |
| Short % of shares outstanding (14 Mar 2023) 4 | 0.74% |
| Shares short (prior month 14 Feb 2023) 4 | 1.48M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 16 June 2022 |
| Ex-dividend date 4 | 01 June 2022 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 55.60% |
| Operating margin (ttm) | 68.09% |
Management effectiveness
| Return on assets (ttm) | 42.83% |
| Return on equity (ttm) | 76.24% |
Income statement
| Revenue (ttm) | 18.56B |
| Revenue per share (ttm) | 76.34 |
| Quarterly revenue growth (yoy) | -43.10% |
| Gross profit (ttm) | 16.07B |
| EBITDA | 12.73B |
| Net income avi to common (ttm) | 10.32B |
| Diluted EPS (ttm) | 40.99 |
| Quarterly earnings growth (yoy) | -44.40% |
Balance sheet
| Total cash (mrq) | 13.43B |
| Total cash per share (mrq) | 55.9 |
| Total debt (mrq) | 274M |
| Total debt/equity (mrq) | 1.49 |
| Current ratio (mrq) | 5.37 |
| Book value per share (mrq) | 76.45 |
Cash flow statement
| Operating cash flow (ttm) | 12.55B |
| Levered free cash flow (ttm) | 10.2B |
© 2023 Yahoo. All rights reserved.
